Informační systém MU
ŠÁNA, Jiří and Ondřej SLABÝ. MicroRNAs and Lung Cancer. In Ondrej Slaby. MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets. New York: Nova Science Publishers, Inc., 2012, p. 95-110. ISBN 978-1-61324-514-9.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name MicroRNAs and Lung Cancer
Authors ŠÁNA, Jiří (203 Czech Republic, guarantor, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, belonging to the institution).
Edition New York, MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets, p. 95-110, 16 pp. 2012.
Publisher Nova Science Publishers, Inc.
Other information
Original language English
Type of outcome Chapter(s) of a specialized book
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Publication form printed version "print"
RIV identification code RIV/00216224:14740/12:00060172
Organization unit Central European Institute of Technology
ISBN 978-1-61324-514-9
Keywords in English microRNAs; lung cancer
Tags ok, rivok
Tags International impact, Reviewed
Changed by Changed by: Olga Křížová, učo 56639. Changed: 18/3/2013 14:59.
Abstract
Lung cancer is one of the most common cancers in the world. Alterations in microRNA (miRNA) funtionality are frequently found in malignancies, including lung cancer. In this chapter, we summarize the current understanding of miRNAs in lung cancer pathogenesis, and highlight their potential in early diagnosis, in extending histological sub-classification techniques, in overcoming drug resistance, and serving not only as biomarkers for risk stratification and outcome prediction, but also as potential therapeutic targets in lung cancer.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
Displayed: 5/8/2024 00:23